ORGANON & CO. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 18,55 USD | +0,71% |
|
+4,10% | +28,64% |
| 09/04 | ORGANON & CO. : Morgan Stanley is Neutraal over het aandeel | ZM |
| 08/04 | Shanghai Henlius Biotech Denosumab Biosimilar HLX14 haalt eindpunt | MT |
Totale waarde
| Fiscaal tijdperk: december | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 7.721 | 7.104 | 3.686 | 4.771 | - | - |
| Bedrijfswaarde 1 | 16.118 | 15.311 | 11.753 | 12.267 | 11.598 | 10.866 |
| K/w-verhouding | 5,73 x | 7,78 x | 3,61 x | 6,1 x | 4,89 x | 4,44 x |
| Dividendrendement | 1,84% | 4,01% | 7,77% | 5,97% | 6,2% | 6,04% |
| Marktkapitalisatie/omzet | 1,22 x | 1,15 x | 0,59 x | 0,75 x | 0,74 x | 0,73 x |
| Bedrijfswaarde/omzet | 2,56 x | 2,48 x | 1,88 x | 1,92 x | 1,8 x | 1,67 x |
| Bedrijfswaarde/EBITDA | 6,77 x | 7,34 x | 6,05 x | 6,14 x | 5,6 x | 5,12 x |
| Bedrijfswaarde/FCF | 8,19 x | 23,1 x | 21,4 x | 14,5 x | 11,1 x | 9,8 x |
| FCF Yield | 12,2% | 4,32% | 4,66% | 6,91% | 8,99% | 10,2% |
| Price to Book | - | -7,99 x | -52,7 x | 8,83 x | 3,57 x | 2,13 x |
| Aantal aandelen (in duizenden) | 253.550 | 254.364 | 255.606 | 257.173 | - | - |
| Referentieprijs 2 | 30,45 | 27,93 | 14,42 | 18,55 | 18,55 | 18,55 |
| Datum van publicatie | 17-02-22 | 16-02-23 | 15-02-24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Omzet 1 | 8.096 | 6.304 | 6.174 | 6.263 | 6.373 | 6.458 | 6.515 |
| EBITDA 1 | - | 2.379 | 2.085 | 1.944 | 1.998 | 2.073 | 2.121 |
| Bedrijfsresultaat (EBIT) 1 | - | 2.184 | 1.873 | 1.874 | 1.868 | 1.942 | 1.977 |
| Operationele Marge | - | 34,64% | 30,34% | 29,92% | 29,32% | 30,07% | 30,34% |
| Resultaat voor belastingen (EBT) | - | 1.529 | 1.122 | 673 | - | - | - |
| Nettowinst (verlies) 1 | 2.160 | 1.351 | 917 | 1.023 | 788 | 981 | 1.082 |
| Nettomarge | 26,68% | 21,43% | 14,85% | 16,33% | 12,36% | 15,19% | 16,61% |
| WPA 2 | - | 5,310 | 3,590 | 3,990 | 3,040 | 3,790 | 4,180 |
| Free Cash Flow 1 | - | 1.968 | 662 | 548 | 847,3 | 1.042 | 1.109 |
| FCF-marge | - | 31,22% | 10,72% | 8,75% | 13,3% | 16,14% | 17,02% |
| Kasstroomconversie (ebitda) | - | 82,72% | 31,75% | 28,19% | 42,41% | 50,29% | 52,26% |
| Kasstroomconversie (nettowinst) | - | 145,67% | 72,19% | 53,57% | 107,53% | 106,25% | 102,46% |
| Dividend per aandeel 2 | - | 0,5600 | 1,120 | 1,120 | 1,108 | 1,150 | 1,120 |
| Datum van publicatie | 14-04-21 | 17-02-22 | 16-02-23 | 15-02-24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: december | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 1.600 | 1.604 | 1.567 | 1.585 | 1.537 | 1.485 | 1.538 | 1.608 | 1.519 | 1.598 | 1.561 | 1.629 | 1.564 | 1.607 | 1.560 |
| EBITDA 1 | 636 | 549 | 647 | 512 | 546 | 380 | 518 | 530 | 447 | 449 | 451 | 515 | 515 | 527 | - |
| Bedrijfsresultaat (EBIT) 1 | 584 | 487 | 594 | 462 | 489 | 328 | 461 | 472 | 430 | 436 | 437,6 | 479,4 | 482,1 | 498 | - |
| Operationele Marge | 36,5% | 30,36% | 37,91% | 29,15% | 31,82% | 22,09% | 29,97% | 29,35% | 28,31% | 27,28% | 28,03% | 29,43% | 30,83% | 30,99% | - |
| Resultaat voor belastingen (EBT) | 389 | 236 | - | 287 | 282 | 111 | 235 | 254 | 80 | 104 | - | - | - | - | - |
| Nettowinst (verlies) | 323 | 202 | - | 234 | 227 | 108 | 177 | 242 | 58 | 546 | - | - | - | - | - |
| Nettomarge | 20,19% | 12,59% | - | 14,76% | 14,77% | 7,27% | 11,51% | 15,05% | 3,82% | 34,17% | - | - | - | - | - |
| WPA | 1,270 | 0,7900 | 1,360 | 0,9200 | 0,8900 | 0,4200 | 0,6900 | 0,9500 | 0,2300 | 2,130 | - | - | - | - | - |
| Dividend per aandeel | - | - | - | - | - | - | - | 0,2800 | - | - | - | - | - | - | - |
| Datum van publicatie | 11-11-21 | 17-02-22 | 05-05-22 | 04-08-22 | 03-11-22 | 16-02-23 | 04-05-23 | 08-08-23 | 02-11-23 | 15-02-24 | - | - | - | - | - |
1USD in Miljoen
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | 8.397 | 8.207 | 8.067 | 7.497 | 6.827 | 6.095 |
| Nettokaspositie 1 | - | - | - | - | - | - | - |
| Hefboom (schuld/ebitda) | - | 3,53 x | 3,936 x | 4,15 x | 3,752 x | 3,294 x | 2,873 x |
| Free Cash Flow 1 | - | 1.968 | 662 | 548 | 847 | 1.042 | 1.109 |
| ROE (netto-inkomsten/eigen vermogen) | - | 67,9% | - | - | 283% | 201% | 80,1% |
| ROA (netto-inkomsten/totale activa) | - | 13% | 11,9% | 9,22% | 9,83% | 9,9% | 9,69% |
| Totale activa 1 | - | 10.395 | 7.726 | 11.094 | 8.013 | 9.910 | 11.163 |
| Nettoactief per aandeel 2 | - | - | -3,500 | -0,2700 | 2,100 | 5,200 | 8,700 |
| Cashflow per aandeel 2 | - | 8,500 | 3,360 | 3,120 | 4,460 | 5,070 | - |
| Capex 1 | - | 192 | 196 | 51 | 228 | 227 | 229 |
| Capex/omzet | - | 3,05% | 3,17% | 0,81% | 3,58% | 3,51% | 3,52% |
| Datum van publicatie | 14-04-21 | 17-02-22 | 16-02-23 | 15-02-24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
B
Verkoop
Koop
Gemiddeld advies
Houden
Aantal analisten
9
Laatste slotkoers
18,55
USD
Gemiddelde koersdoel
21,5
USD
Spread / Gemiddelde doel
+15,90%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +28,64% | 4,77 mld. | |
| +25,83% | 661 mld. | |
| +27,00% | 566 mld. | |
| -6,76% | 352 mld. | |
| +20,34% | 332 mld. | |
| +3,00% | 283 mld. | |
| +13,09% | 231 mld. | |
| +5,46% | 200 mld. | |
| -9,61% | 195 mld. | |
| -6,26% | 145 mld. |
